SERA · Healthcare · $77M
$2.01-0.50%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“매출 3만 달러 — 전 분기 1만4천 달러에서 두 배 이상 늘었고, 지난해 3분기 1만6천 달러와 비교해도 가장 높은 수준이에요.”
In the company's words · 2026 2분기 earnings call